These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1154 related articles for article (PubMed ID: 3584216)

  • 1. Phase II trial of recombinant leukocyte A interferon in advanced malignant melanoma.
    Elsässer-Beile U; Drees N; Neumann HA; Schöpf E
    J Cancer Res Clin Oncol; 1987; 113(3):273-8. PubMed ID: 3584216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recombinant leukocyte A interferon in metastasized malignant melanoma].
    Elsässer-Beile U; Schöpf E; Neumann HA; Drews H; Hundhammer K; Balda BR
    Dtsch Med Wochenschr; 1987 Mar; 112(10):373-7. PubMed ID: 3816582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients.
    Sherwin SA; Knost JA; Fein S; Abrams PG; Foon KA; Ochs JJ; Schoenberger C; Maluish AE; Oldham RK
    JAMA; 1982 Nov; 248(19):2461-6. PubMed ID: 6752447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of a combination of interferon-beta ser and interferon-gamma in patients with advanced malignant melanoma.
    Schiller JH; Storer B; Bittner G; Willson JK; Borden EC
    J Interferon Res; 1988 Oct; 8(5):581-9. PubMed ID: 3148669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of recombinant leukocyte A interferon in patients with advanced chronic lymphocytic leukemia.
    Foon KA; Bottino GC; Abrams PG; Fer MF; Longo DL; Schoenberger CS; Oldham RK
    Am J Med; 1985 Feb; 78(2):216-20. PubMed ID: 3970047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of recombinant interferon alfa-2a (Roferon-A) in metastatic melanoma using two different schedules .
    Legha SS; Papadopoulos NE; Plager C; Ring S; Chawla SP; Evans LM; Benjamin RS
    J Clin Oncol; 1987 Aug; 5(8):1240-6. PubMed ID: 3625246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanoma.
    Dorval T; Palangie T; Jouve M; Garcia-Giralt E; Israel L; Falcoff E; Schwab D; Pouillart P
    Cancer; 1986 Jul; 58(2):215-8. PubMed ID: 3719515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant interferon alfa-2a in advanced malignant melanoma. A phase I-II study in combination with DTIC.
    McLeod GR; Thomson DB; Hersey P
    Int J Cancer Suppl; 1987; 1():31-5. PubMed ID: 3476475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of metastatic malignant melanoma with recombinant interferon alfa-2b.
    Dorval T; Palangie T; Jouve M; Garcia-Giralt E; Falcoff E; Schwab D; Lerminier M; Pouillart P
    Invest New Drugs; 1987; 5 Suppl():S61-3. PubMed ID: 3597003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma.
    Mittelman A; Huberman M; Puccio C; Fallon B; Tessitore J; Savona S; Eyre R; Gafney E; Wick M; Skelos A
    Cancer; 1990 Aug; 66(4):664-9. PubMed ID: 2386896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant leukocyte A interferon in advanced breast cancer. Results of a phase II efficacy trial.
    Sherwin SA; Mayer D; Ochs JJ; Abrams PG; Knost JA; Foon KA; Fein S; Oldham RK
    Ann Intern Med; 1983 May; 98(5 Pt 1):598-602. PubMed ID: 6342490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients.
    Jones GJ; Itri LM
    Cancer; 1986 Apr; 57(8 Suppl):1709-15. PubMed ID: 3948143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in skin malignant tumors].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):936-42. PubMed ID: 2985007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma.
    Creagan ET; Ahmann DL; Long HJ; Frytak S; Sherwin SA; Chang MN
    Cancer Treat Rep; 1987 Sep; 71(9):843-4. PubMed ID: 3113730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase-II study of recombinant alpha 2-interferon in advanced malignant melanoma.
    Coates A; Rallings M; Hersey P; Swanson C
    J Interferon Res; 1986 Feb; 6(1):1-4. PubMed ID: 2871116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of recombinant alpha-interferon in malignant melanoma.
    Neefe JR; Legha SS; Markowitz A; Salmon S; Meyskens F; Groopman J; Campion M; Evans L
    Am J Clin Oncol; 1990 Dec; 13(6):472-6. PubMed ID: 2239801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of multiple myeloma with recombinant interferon alfa-2a.
    Ohno R; Kimura K
    Cancer; 1986 Apr; 57(8 Suppl):1685-8. PubMed ID: 3948139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of recombinant beta (IFN-betaser) interferon in the treatment of metastatic breast cancer.
    Barreras L; Vogel CL; Koch G; Marcus SG
    Invest New Drugs; 1988 Sep; 6(3):211-5. PubMed ID: 3192387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of recombinant beta ser 17 interferon in the treatment of cancer.
    Sarna G; Pertcheck M; Figlin R; Ardalan B
    Cancer Treat Rep; 1986 Dec; 70(12):1365-72. PubMed ID: 3791249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of recombinant alfa-2a interferon in patients with advanced bone sarcomas.
    Edmonson JH; Long HJ; Frytak S; Smithson WA; Itri LM
    Cancer Treat Rep; 1987; 71(7-8):747-8. PubMed ID: 3038315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.